Clinical Research Directory
Browse clinical research sites, groups, and studies.
Nalbuphine as Adjuvant During Bilateral Suprazygomatic Maxillary Nerve Block for Pediatric Cleft Palate Repair
Sponsor: Assiut University
Summary
The aim of this study is to evaluate the efficacy of adding nalbuphine to bupivacaine via suprazygomatic nerve block for postoperative pain control and emergence agitation management in pediatrics aged from to 1 to 7 years who were maintained on sevoflurane inhalational anesthesia and scheduled for cleft lip and palate operation.
Official title: Nalbuphine as Adjuvant During Bilateral Suprazygomatic Maxillary Nerve Block for Pediatric Cleft Palate Repair: A Prospective, Randomized Comparative, Controlled Double-blind Study.
Key Details
Gender
All
Age Range
12 Months - 7 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2023-07-31
Completion Date
2026-01-31
Last Updated
2026-09-01
Healthy Volunteers
Yes
Interventions
Nalbuphine
bupivacaine 0.125% of 0.2 ml/kg and 0.1 mg/kg nalbuphine
Bupivacaine
30 patients received SMB using bupivacaine 0.125% of 0.2 ml/kg on each side (with maximum volume of 4 ml).
Locations (1)
Mohamed Fathy Mostafa
Asyut, Egypt